| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| anifrolumab | interferon alpha/beta receptor 1 | biotech | NA | drugbank , DGIDB | Lupus Erythematosus Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
5.3 | approved,investigational | inhibitor,antibody |
| anifrolumab | interferon alpha/beta receptor 2 | NA | Successful target | TTD , DGIDB | Lupus Erythematosus Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.65 | phase 3 | unknown |
| click here to return to the previous page | ||||||||